These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26048124)

  • 1. [Not Available].
    Utzt MJ
    MMW Fortschr Med; 2015 Jun; 157 Suppl 2():54. PubMed ID: 26048124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and treatment of hepatic encephalopathy].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Overt Hepatic Encephalopathy.
    Sussman NL
    Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatic encephalopathy. L-ornithine-L-aspartate stimulate detoxification capacity of the liver].
    Ameri AA
    MMW Fortschr Med; 2010 Jun; 152(22):42-3. PubMed ID: 20590033
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
    MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain].
    MMW Fortschr Med; 2004 Jan; 146(5):51. PubMed ID: 15035428
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimal treatment of hepatic encephalopathy.
    Waghray A; Waghray N; Kanna S; Mullen K
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic encephalopathy and liver transplantation].
    Fehérvári I; Nemes B; Görög D; Gerlei Z; Kóbori L
    Magy Seb; 2012 Apr; 65(2):58-62. PubMed ID: 22512880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatic encephalopathy. Early therapy is most important!].
    MMW Fortschr Med; 2014 Nov; 156(19):28. PubMed ID: 25510011
    [No Abstract]   [Full Text] [Related]  

  • 11. A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment.
    Soárez PC; Oliveira AC; Padovan J; Parise ER; Ferraz MB
    Arq Gastroenterol; 2009; 46(3):241-7. PubMed ID: 19918694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy: rifaximin.
    Bajaj JS; Riggio O
    Hepatology; 2010 Oct; 52(4):1484-8. PubMed ID: 20814894
    [No Abstract]   [Full Text] [Related]  

  • 13. Ammonia abolishers: antibiotics for hepatic encephalopathy.
    Felicilda-Reynaldo RF
    Medsurg Nurs; 2012; 21(3):173-5; quiz 176. PubMed ID: 22866441
    [No Abstract]   [Full Text] [Related]  

  • 14. Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What?
    Henderson PK; Herrera JL
    Clin Liver Dis; 2015 Aug; 19(3):487-95. PubMed ID: 26195203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pay more attention to hepatic encephalopathy].
    Labenz J
    MMW Fortschr Med; 2014 Feb; 156(2):60-1. PubMed ID: 24934059
    [No Abstract]   [Full Text] [Related]  

  • 17. The rectal administration of lactulose.
    Ratnaike RN; Hicks EP; Hislop IG
    Aust N Z J Med; 1975 Apr; 5(2):137-40. PubMed ID: 240347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACP Journal Club. Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy.
    Kowdley KV; Burman BE
    Ann Intern Med; 2013 Oct; 159(8):JC8. PubMed ID: 24126669
    [No Abstract]   [Full Text] [Related]  

  • 19. What type of probiotic was used?
    Montagnese S; Amodio P; Angeli P
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):471-2. PubMed ID: 22395181
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifaximin may have a dramatic effect on hepatic encephalopathy.
    Lamb C; Reddy AV
    Clin Med (Lond); 2012 Oct; 12(5):489-90. PubMed ID: 23101155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.